We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Unveils COVID-19 Vaccine Candidate Trial Protocol
AstraZeneca has released the trial protocols for the late-stage study of its coronavirus vaccine candidate, AZD1222, amid mounting calls for transparency as its investigation into an adverse event continues.